Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Stocks pull back from five-month high

Wed, 23rd Oct 2013 17:01

- Miners, banks weigh on Footsie- Money-market rates spike in China- RSA up on bid speculationtechMARK 2,624.47 -0.41%FTSE 100 6,674.48 -0.32%FTSE 250 15,494.97 -0.11%The FTSE 100 finished in negative territory for the first time in 10 trading sessions on Wednesday as traders took profits after the index hit a five-month high on the previous day.Concerns over the economic outlook in China and weakness in the heavyweight mining and banking sectors weighed on London's benchmark index today, which finished down 21.18 points at 6,674.48. The FTSE 100 was pulling back after hitting its highest closing levels since May 28th on Tuesday.The bullish mood was dampened today by concerns over the Chinese economy after the news that debt write-offs at China's biggest lenders had tripled in the first half. Meanwhile, the People's Bank of China refrained from adding liquidity to the market through new reverse repurchase operations which led to a sharp increase in the country's benchmark money-market rate.Chief Market Analyst Michael Hewson from CMC Markets said that the reports have prompted "concerns that a fiscal tightening could well see a slowdown in the recent recovery in the Chinese economy".However, he said: "In reality we have been due a pullback for some time now given the recent run up, and given the fact that a lot of this week's earnings reports have shown some worrying signs of weakness."Miners and banks fall, while RSA jumpsMining stocks including Antofagasta and Anglo American were out of favour on concerns over China in addition to gloomy results from US bellwether Caterpillar, which makes heavy machinery for the mining and ground-moving industries. The firm disappointed Wall Street forecasts with its full-year guidance owing to weak mining orders, saying that "significant risks and uncertainties" could temper global economic growth next year.Banks all over Europe were lower after the European Central Bank said it would start to review the balance sheets of 130 institutions across the continent. RBS, Barclays, Lloyds, HSBC and Standard Chartered were all registering losses in London.Insurance firm RSA was a high riser on speculation that the firm could be the target of a takeover bid. Reuters cited traders as touting Italian group Generali, Swiss firm Zurich Financial and UK peer Aviva as potential bidders.Chip designer ARM Holdings fell for the second straight day as investors gave a cool reaction to its third-quarter results. JPMorgan Cazenove said this morning that it sees "no reason to be building positions at this time and would take profits in the short term."A number of stocks were also trading in the red after going ex-dividend, including Smiths Group, BAE System, Rolls-Royce, John Menzies, Senior, William Hill, Rank Group, Barratt Developments and JD Wetherspoon.Banknote printer and ID services firm De La Rue was a big mover with shares sinking after the company warned that it would miss its full-year profit target by £10m owing to "challenging trading conditions".Drugs group GlaxoSmithKline beat earnings growth expectations in the third quarter by cutting back office and drug research and development costs were amplified by a lower tax rate. However, shares fell after revenue growth of 1% to £6.51bn missed forecacts.FTSE 100 - RisersRSA Insurance Group (RSA) 127.00p +2.50%Persimmon (PSN) 1,256.00p +2.36%United Utilities Group (UU.) 716.50p +1.63%International Consolidated Airlines Group SA (CDI) (IAG) 364.80p +1.62%ITV (ITV) 195.00p +1.51%Hargreaves Lansdown (HL.) 1,171.00p +1.47%Legal & General Group (LGEN) 213.00p +1.43%Babcock International Group (BAB) 1,260.00p +1.37%Travis Perkins (TPK) 1,805.00p +1.29%Shire Plc (SHP) 2,525.00p +1.28%FTSE 100 - FallersARM Holdings (ARM) 953.50p -5.03%Antofagasta (ANTO) 865.50p -4.26%Smiths Group (SMIN) 1,397.00p -3.99%Anglo American (AAL) 1,495.00p -3.92%Royal Bank of Scotland Group (RBS) 352.10p -2.73%GlaxoSmithKline (GSK) 1,570.50p -1.91%Sage Group (SGE) 327.00p -1.83%CRH (CRH) 1,517.00p -1.81%Barclays (BARC) 268.20p -1.61%Standard Chartered (STAN) 1,500.00p -1.45%FTSE 250 - RisersPace (PIC) 323.80p +11.66%Laird (LRD) 243.90p +8.06%IP Group (IPO) 149.00p +5.23%Home Retail Group (HOME) 192.10p +4.23%AL Noor Hospitals Group (ANH) 918.00p +3.73%Supergroup (SGP) 1,186.00p +3.31%Dixons Retail (DXNS) 48.20p +3.26%BBA Aviation (BBA) 336.60p +2.97%BTG (BTG) 407.90p +2.85%Kenmare Resources (KMR) 22.39p +2.85%FTSE 250 - FallersDe La Rue (DLAR) 885.50p -9.73%International Personal Finance (IPF) 623.00p -6.81%Telecity Group (TCY) 779.50p -5.74%Essar Energy (ESSR) 120.20p -5.43%Ferrexpo (FXPO) 184.70p -4.74%Evraz (EVR) 128.40p -4.32%Kazakhmys (KAZ) 251.40p -4.05%Centamin (DI) (CEY) 49.76p -4.03%Premier Oil (PMO) 328.50p -3.38%AZ Electronic Materials SA (DI) (AZEM) 286.90p -3.07%BC
More News
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more
27 Nov 2023 08:02

GSK receives 'positive' headline results from phase III trial

(Sharecast News) - Drugmaker GSK announced on Monday that it had received positive headline results from a planned interim efficacy analysis from a phase III trial evaluating its elantamab mafodotin asset.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.